Home Cart Sign in  
Chemical Structure| 509093-47-4 Chemical Structure| 509093-47-4

Structure of IRAK-1-4 Inhibitor I
CAS No.: 509093-47-4

Chemical Structure| 509093-47-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

IRAK-1-4 Inhibitor I is a IRAK-4 inhibitor with IC50 of 200 nM.

Synonyms: IRAK-1/4 Inhibitor I; IRAK-1/4 Inhibitor

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of IRAK-1-4 Inhibitor I

CAS No. :509093-47-4
Formula : C20H21N5O4
M.W : 395.41
SMILES Code : O=C(C1=CC=CC([N+]([O-])=O)=C1)NC2=NC3=CC=CC=C3N2CCN4CCOCC4
Synonyms :
IRAK-1/4 Inhibitor I; IRAK-1/4 Inhibitor
MDL No. :MFCD09752602
InChI Key :QTCFYQHZJIIHBS-UHFFFAOYSA-N
Pubchem ID :11983295

Safety of IRAK-1-4 Inhibitor I

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of IRAK-1-4 Inhibitor I

TLR

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Malme-3M 2.5 μM 48 h Inhibition of IRAK-1,-4 signaling enhanced cell apoptosis, with more significant effects when combined with vinblastine PMC3677596
A375 2.5 μM 48 h Inhibition of IRAK-1,-4 signaling enhanced cell apoptosis, with more significant effects when combined with vinblastine PMC3677596
NCM460 cells 50 μM 2 h To evaluate the effect of IRAK1/4 inhibitor on DSS-induced IL-8 secretion. Results showed that IRAK1/4 inhibitor had no effect on DSS-induced IL-8 secretion. PMC2688460
SK-OV-3 ovarian cancer cells 10 µM 24 h Evaluate the effect of HS-243 on cancer cell survival, showing that HS-243 alone inhibited cell survival by 13%, and in combination with IL-1β, it inhibited cell survival by 46%. PMC7008364
AN3-CA pancreatic cancer cells 10 µM 24 h Evaluate the effect of HS-243 on cancer cell survival, showing that HS-243 alone inhibited cell survival by 21%, and in combination with IL-1β, it inhibited cell survival by 33%. PMC7008364
THP-1 human macrophages 10 µM 24 h Evaluate the effect of HS-243 on inflammatory responses in macrophages after LPS stimulation, showing that HS-243 significantly inhibited the secretion of IL-8, CD14, GRO-α, MIP-1α, MIP-3α, uPAR, Osteopontin, MMP-9, MCP-1, I-TAC, TIM-3, IP-10, GDF-15, and RANTES. PMC7008364
Human rheumatoid arthritis fibroblast-like synoviocytes (RA-FLS) 10 µM 24 h Evaluate the effect of HS-243 on cytokine/chemokine responses after LPS stimulation, showing that HS-243 significantly inhibited the expression of CCL5, CXCL12, MIF, and IL-18. PMC7008364
Bone marrow-derived dendritic cells (BMDCs) 50 μM 2 h Blocking IRAK1/4 signaling significantly reduced S. pneumoniae-induced IL-23 production and completely abolished the inhibitory effects of morphine on IL-23 production. PMC3060476

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
NSG mice A375 melanoma xenograft model Intratumoral injection 35 mg/kg Every 2 days for 5 days Combination therapy significantly delayed tumor growth and prolonged survival PMC3677596

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.53mL

0.51mL

0.25mL

12.65mL

2.53mL

1.26mL

25.29mL

5.06mL

2.53mL

References

 

Historical Records

Categories